BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $684,000 | -10.8% | 8,499 | -10.8% | 0.07% | -2.9% |
| Q2 2021 | $767,000 | -10.5% | 9,524 | -4.8% | 0.07% | -9.1% |
| Q1 2021 | $857,000 | -1.9% | 9,999 | -8.2% | 0.08% | -8.3% |
| Q4 2020 | $874,000 | -0.7% | 10,893 | -0.4% | 0.08% | -8.7% |
| Q3 2020 | $880,000 | -5.6% | 10,937 | +1.1% | 0.09% | -11.5% |
| Q2 2020 | $932,000 | -35.8% | 10,823 | -39.4% | 0.10% | -18.8% |
| Q1 2020 | $1,451,000 | -43.0% | 17,873 | -41.3% | 0.13% | +9.4% |
| Q4 2019 | $2,546,000 | -5.4% | 30,445 | -1.1% | 0.12% | -10.0% |
| Q3 2019 | $2,692,000 | +14.9% | 30,779 | +7.6% | 0.13% | +13.0% |
| Q2 2019 | $2,343,000 | +9.1% | 28,604 | +8.3% | 0.12% | +5.5% |
| Q1 2019 | $2,147,000 | +17.8% | 26,405 | -4.6% | 0.11% | -2.7% |
| Q4 2018 | $1,822,000 | -18.3% | 27,688 | -4.3% | 0.11% | +6.7% |
| Q3 2018 | $2,231,000 | +4.0% | 28,942 | -0.4% | 0.10% | +1.0% |
| Q2 2018 | $2,146,000 | +14.9% | 29,064 | +1.2% | 0.10% | +18.2% |
| Q1 2018 | $1,868,000 | -30.4% | 28,718 | -30.8% | 0.09% | -2.2% |
| Q4 2017 | $2,684,000 | -5.2% | 41,530 | -7.9% | 0.09% | -4.3% |
| Q3 2017 | $2,831,000 | +5.3% | 45,108 | +1.6% | 0.09% | +1.1% |
| Q2 2017 | $2,688,000 | +0.3% | 44,405 | -14.1% | 0.09% | +6.9% |
| Q1 2017 | $2,680,000 | +28.7% | 51,683 | +10.0% | 0.09% | +10.1% |
| Q4 2016 | $2,083,000 | -16.8% | 46,974 | -10.8% | 0.08% | -11.2% |
| Q3 2016 | $2,505,000 | -3.9% | 52,633 | -8.7% | 0.09% | -11.0% |
| Q2 2016 | $2,606,000 | +11.6% | 57,629 | +1.4% | 0.10% | +7.5% |
| Q1 2016 | $2,335,000 | +5.9% | 56,832 | -1.7% | 0.09% | +10.7% |
| Q4 2015 | $2,205,000 | +22.0% | 57,791 | +5.0% | 0.08% | +13.5% |
| Q3 2015 | $1,808,000 | -52.3% | 55,024 | +1.4% | 0.07% | -50.3% |
| Q2 2015 | $3,793,000 | -9.1% | 54,239 | -10.9% | 0.15% | +4.2% |
| Q1 2015 | $4,171,000 | -13.7% | 60,899 | -7.7% | 0.14% | -13.3% |
| Q4 2014 | $4,834,000 | -15.1% | 65,955 | -16.8% | 0.16% | -2.9% |
| Q3 2014 | $5,692,000 | +5.2% | 79,313 | +6.0% | 0.17% | +3.0% |
| Q2 2014 | $5,412,000 | -1.9% | 74,855 | -0.2% | 0.16% | -4.1% |
| Q1 2014 | $5,517,000 | -0.6% | 74,979 | -6.1% | 0.17% | +11.7% |
| Q4 2013 | $5,553,000 | -8.4% | 79,839 | -13.5% | 0.15% | +2.0% |
| Q3 2013 | $6,065,000 | -15.4% | 92,321 | -10.8% | 0.15% | -9.6% |
| Q2 2013 | $7,172,000 | – | 103,543 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |